Form 4: Puma Biotechnology Director Alessandra Cesano Reports Stock Transactions

Director Alessandra Cesano reported the acquisition of 27,000 shares of Puma Biotechnology common stock and the disposal of 54,000 shares on June 18, 2024.

Summary

• Alessandra Cesano, a director of Puma Biotechnology, reported changes in beneficial ownership of the company's stock.
• On June 18, 2024, Ms. Cesano acquired 27,000 shares of common stock at a price of $0.
• On the same day, Ms. Cesano disposed of 54,000 shares of common stock.
• Following these transactions, Ms. Cesano beneficially owns 54,000 shares of Puma Biotechnology.
• The acquired shares represent Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the biotechnology industry. Investors often monitor these filings for insights into management's confidence in the company's prospects.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company insiders as an indicator of management's view of the company's value.

Key Dates